approval
saveMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
community read0 votes
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalMar 26, 2026 · 194d ago
- approvalMEKINIST (TRAMETINIB) — FDA approvalMar 26, 2026 · 194d ago
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalApr 21, 2025 · 533d ago
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalApr 7, 2025 · 547d ago
- approvalMEKINIST (TRAMETINIB) — FDA approvalApr 7, 2025 · 547d ago
- approvalMEKINIST (TRAMETINIB) — FDA approvalMar 19, 2025 · 566d ago
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalMar 19, 2025 · 566d ago
- approvalMEKINIST (TRAMETINIB) — FDA approvalMar 7, 2025 · 578d ago
same company · ±60 days · 6
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalJan 28, 2022
- approvalSpexotras: MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalJan 28, 2022
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalFeb 4, 2022
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalDec 22, 2021
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalDec 22, 2021
- approvalinclisiran: LEQVIO (INCLISIRAN SODIUM) — FDA approvalDec 22, 2021
comments(0)
5-min edit window · permanent after that